Terms: = Leukemia AND ASXL1, ENSG00000171456, 171023, Q8IXJ9, MGC71111, MGC117280, KIAA0978
719 results:
1. Measurable residual disease monitoring by ddPCR in the early posttransplant period complements the traditional MFC method to predict relapse after HSCT in AML/MDS: a multicenter retrospective study.
Chen W; Huang J; Zhao Y; Huang L; Yuan Z; Gu M; Xu X; Shi J; Luo Y; Yu J; Lai X; Liu L; Fu H; Bao C; Huang X; Zheng Z; Huang H; Hu X; Zhao Y
J Transl Med; 2024 Apr; 22(1):410. PubMed ID: 38689269
[TBL] [Abstract] [Full Text] [Related]
2. Genetic mutations and immune microenvironment: unveiling the connection to AML prognosis.
Hu Z; Yang Y; Li J; Hu Z
Hematology; 2024 Dec; 29(1):2346965. PubMed ID: 38687637
[TBL] [Abstract] [Full Text] [Related]
3. Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients.
Borsi E; Vigliotta I; Poletti A; Mazzocchetti G; Solli V; Zazzeroni L; Martello M; Armuzzi S; Taurisano B; Kanapari A; Pistis I; Zamagni E; Pantani L; Rocchi S; Mancuso K; Tacchetti P; Rizzello I; Rizzi S; Dan E; Sinigaglia B; Cavo M; Terragna C
Cells; 2024 Apr; 13(8):. PubMed ID: 38667272
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical Characteristics and Prognosis of Acute Myeloid leukemia Patients with
Shan RQ; Huang S; Gu ZY; Wang N; Liu DH; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):327-334. PubMed ID: 38660832
[TBL] [Abstract] [Full Text] [Related]
5. A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias.
Mavridou E; Lema Fernandez AG; Nardelli C; Pierini V; Quintini M; Arniani S; Di Giacomo D; Crescenzi B; Matteucci C; Sambani C; Mecucci C
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23235. PubMed ID: 38656651
[TBL] [Abstract] [Full Text] [Related]
6. A Case of Chronic Eosinophilic leukemia with CSF3R-Mutant Clone and Transformed to Secondary Acute Myeloid leukemia.
Wu Y; Yang X
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623671
[TBL] [Abstract] [Full Text] [Related]
7. Differential prognostic values of the three AKT isoforms in acute myeloid leukemia.
Corre E; Soum C; Pfeifer R; Bessière C; Dailhau S; Marbœuf C; Meggetto F; Touriol C; Récher C; Bousquet M; Pyronnet S
Sci Rep; 2024 Mar; 14(1):7070. PubMed ID: 38528080
[TBL] [Abstract] [Full Text] [Related]
8. Natural history of clonal haematopoiesis seen in real-world haematology settings.
Patel SA; Gerber WK; Zheng R; Khanna S; Hutchinson L; Abel GA; Cerny J; DaSilva BA; Zhang TY; Ramanathan M; Khedr S; Selove W; Woda B; Miron PM; Higgins AW; Gerber JM
Br J Haematol; 2024 May; 204(5):1844-1855. PubMed ID: 38522849
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical analysis of allogeneic hematopoietic stem cell transplantation for seven cases of acute myeloid leukemia with BCR::ABL1 fusion].
Hao MZ; Zhao XL; Zhang XY; Shi YY; Gong M; Zhang LN; Chen SL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):995-1000. PubMed ID: 38503522
[No Abstract] [Full Text] [Related]
10. Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
Chien KS; Ong F; Kim K; Li Z; Kanagal-Shamanna R; DiNardo CD; Takahashi K; Montalban-Bravo G; Hammond D; Sasaki K; Pierce SA; Kantarjian HM; Garcia-Manero G
Cancer Med; 2024 Mar; 13(5):e7093. PubMed ID: 38497538
[TBL] [Abstract] [Full Text] [Related]
11. AML with RUNX1::RUNX1T1 Cooperating two Mutations Relapsed Quickly after Achieving CR.
XinhongYang ; Wu Y; Yang X; Wu X; Chen Y; Zhang R; Zhang Z
Clin Lab; 2024 Mar; 70(3):. PubMed ID: 38469780
[TBL] [Abstract] [Full Text] [Related]
12. Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid leukemia.
Cieniewicz B; Oliveira E; Saxton M; Torabi D; Bhatta A; Kukutla P; Arballo A; Yang Z; Yu B; Fate M; Ning H; Corey L; Maiti A; Corey D
Clin Cancer Res; 2024 May; 30(9):1878-1888. PubMed ID: 38451195
[TBL] [Abstract] [Full Text] [Related]
13. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
Patnaik MM; Tefferi A
Am J Hematol; 2024 Jun; 99(6):1142-1165. PubMed ID: 38450850
[TBL] [Abstract] [Full Text] [Related]
14. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
Mata DA; Lee JK; Shanmugam V; Marcus CB; Schrock AB; Williams EA; Ritterhouse LL; Hickman RA; Janovitz T; Patel NR; Kroger BR; Ross JS; Mirza KM; Oxnard GR; Vergilio JA; Elvin JA; Benhamida JK; Decker B; Xu ML
Histopathology; 2024 Jun; 84(7):1224-1237. PubMed ID: 38422618
[TBL] [Abstract] [Full Text] [Related]
15. Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.
Kubota Y; Gu X; Terkawi L; Bodo J; Przychodzen BP; Awada H; Williams N; Gurnari C; Kawashima N; Aly M; Durmaz A; Mori M; Ponvilawan B; Kewan T; Bahaj W; Meggendorfer M; Jha BK; Visconte V; Rogers HJ; Haferlach T; Maciejewski JP
Nat Commun; 2024 Feb; 15(1):1832. PubMed ID: 38418452
[TBL] [Abstract] [Full Text] [Related]
16. [The Correlation of Gene Mutation and Clinical Characteristics in Patients with Myelodysplastic Syndrome and Prognostic Analysis].
Zhang WW; Zhang YL; Ren CC; Wu TK; Liu B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):176-183. PubMed ID: 38387918
[TBL] [Abstract] [Full Text] [Related]
17. [Clinical Significance of Genetic and Molecular Changes in Primary Myeloid Sarcoma].
Jiang YJ; Zhang CF; Wang HX; Zhao L; Zhang FF; Han XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):27-32. PubMed ID: 38387895
[TBL] [Abstract] [Full Text] [Related]
18. Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt-related transcription factor 1 mutation: A single-center retrospective analysis.
Wang LY; Li Y; Jiang Q; Jiang H; Wang Y; Xu LP; Zhang XH; Liu KY; Tang FF
Hematol Oncol; 2024 Mar; 42(2):e3256. PubMed ID: 38367260
[TBL] [Abstract] [Full Text] [Related]
19. Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax.
Bazinet A; Desikan SP; Li Z; Rodriguez-Sevilla JJ; Venugopal S; Urrutia S; Montalban-Bravo G; Sasaki K; Chien KS; Hammond D; Kanagal-Shamanna R; Ganan-Gomez I; Kadia TM; Borthakur G; DiNardo CD; Daver NG; Jabbour EJ; Ravandi F; Kantarjian H; Garcia-Manero G
Clin Cancer Res; 2024 Apr; 30(7):1319-1326. PubMed ID: 38300723
[TBL] [Abstract] [Full Text] [Related]
20. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
Tefferi A; Vannucchi AM; Barbui T
Am J Hematol; 2024 Apr; 99(4):697-718. PubMed ID: 38269572
[TBL] [Abstract] [Full Text] [Related]
[Next]